Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 9 | 2025 | 2295 | 2.530 |
Why?
|
| Gastroesophageal Reflux | 2 | 2023 | 234 | 1.270 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2022 | 293 | 1.090 |
Why?
|
| Emigrants and Immigrants | 3 | 2017 | 136 | 0.910 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2017 | 161 | 0.890 |
Why?
|
| Polysomnography | 1 | 2024 | 185 | 0.830 |
Why?
|
| Citrulline | 1 | 2023 | 45 | 0.800 |
Why?
|
| Cannabinoids | 1 | 2024 | 161 | 0.760 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 318 | 0.690 |
Why?
|
| Obesity | 3 | 2024 | 2992 | 0.680 |
Why?
|
| Noninvasive Ventilation | 1 | 2020 | 51 | 0.650 |
Why?
|
| Dermatitis, Atopic | 1 | 2023 | 329 | 0.620 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 257 | 0.580 |
Why?
|
| Sleep | 1 | 2024 | 755 | 0.570 |
Why?
|
| Unsafe Sex | 2 | 2014 | 60 | 0.520 |
Why?
|
| Hospital Mortality | 1 | 2020 | 911 | 0.500 |
Why?
|
| Risk-Taking | 1 | 2017 | 348 | 0.450 |
Why?
|
| Sexual Behavior | 2 | 2017 | 485 | 0.430 |
Why?
|
| Social Support | 1 | 2017 | 618 | 0.410 |
Why?
|
| Substance-Related Disorders | 3 | 2017 | 1083 | 0.410 |
Why?
|
| Ornithine | 2 | 2023 | 26 | 0.400 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 220 | 0.390 |
Why?
|
| Morbidity | 2 | 2023 | 324 | 0.370 |
Why?
|
| Arginine | 2 | 2023 | 271 | 0.360 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2025 | 395 | 0.340 |
Why?
|
| New Orleans | 4 | 2017 | 14 | 0.300 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 5472 | 0.250 |
Why?
|
| Comorbidity | 2 | 2021 | 1622 | 0.250 |
Why?
|
| Pneumonia | 2 | 2023 | 639 | 0.250 |
Why?
|
| Humans | 18 | 2025 | 137585 | 0.240 |
Why?
|
| HIV Infections | 2 | 2017 | 2836 | 0.240 |
Why?
|
| Health Surveys | 3 | 2017 | 514 | 0.230 |
Why?
|
| Adult | 8 | 2024 | 37929 | 0.200 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 50 | 0.200 |
Why?
|
| Causality | 1 | 2023 | 126 | 0.190 |
Why?
|
| Critical Care Outcomes | 1 | 2020 | 12 | 0.180 |
Why?
|
| Status Asthmaticus | 1 | 2020 | 11 | 0.180 |
Why?
|
| Marijuana Use | 1 | 2024 | 206 | 0.170 |
Why?
|
| Quality of Life | 2 | 2023 | 2892 | 0.170 |
Why?
|
| Muscarinic Antagonists | 1 | 2019 | 29 | 0.160 |
Why?
|
| Dyspnea | 1 | 2022 | 254 | 0.160 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 301 | 0.150 |
Why?
|
| Exercise Test | 1 | 2022 | 625 | 0.150 |
Why?
|
| Middle Aged | 4 | 2024 | 33479 | 0.140 |
Why?
|
| Male | 7 | 2024 | 67762 | 0.130 |
Why?
|
| Cannabis | 1 | 2024 | 494 | 0.130 |
Why?
|
| Life Style | 1 | 2019 | 490 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2020 | 5742 | 0.130 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 363 | 0.130 |
Why?
|
| Alcoholism | 1 | 2023 | 807 | 0.130 |
Why?
|
| Female | 6 | 2024 | 73304 | 0.120 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 645 | 0.120 |
Why?
|
| Disease Management | 1 | 2019 | 628 | 0.120 |
Why?
|
| Critical Care | 1 | 2020 | 601 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 515 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2021 | 767 | 0.120 |
Why?
|
| Phenotype | 1 | 2023 | 3196 | 0.110 |
Why?
|
| Critical Illness | 1 | 2020 | 811 | 0.110 |
Why?
|
| Sepsis | 1 | 2020 | 617 | 0.110 |
Why?
|
| Weight Loss | 1 | 2019 | 787 | 0.110 |
Why?
|
| Condoms | 1 | 2014 | 103 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 2069 | 0.100 |
Why?
|
| Volunteers | 1 | 2013 | 29 | 0.100 |
Why?
|
| Disease Progression | 1 | 2020 | 2757 | 0.100 |
Why?
|
| Risk Factors | 3 | 2017 | 10388 | 0.100 |
Why?
|
| Behavior, Addictive | 1 | 2013 | 81 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2023 | 15657 | 0.100 |
Why?
|
| Social Identification | 1 | 2013 | 67 | 0.100 |
Why?
|
| Sexual Partners | 1 | 2013 | 186 | 0.090 |
Why?
|
| Diet | 1 | 2019 | 1278 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 163 | 0.090 |
Why?
|
| Community Health Services | 1 | 2013 | 227 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2013 | 232 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2023 | 7604 | 0.090 |
Why?
|
| Young Adult | 3 | 2017 | 13209 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 188 | 0.080 |
Why?
|
| Students, Medical | 1 | 2013 | 348 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1477 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 2844 | 0.060 |
Why?
|
| Adolescent | 2 | 2022 | 21513 | 0.050 |
Why?
|
| Mycobacterium avium Complex | 1 | 2021 | 88 | 0.040 |
Why?
|
| Aged | 1 | 2020 | 23961 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2022 | 279 | 0.040 |
Why?
|
| United States | 1 | 2014 | 14841 | 0.030 |
Why?
|
| Binge Drinking | 1 | 2013 | 43 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 2199 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 4060 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 10811 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2734 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5131 | 0.010 |
Why?
|